Skip to main content
. 2007 May 14;13(18):2622–2625. doi: 10.3748/wjg.v13.i18.2622

Figure 2.

Figure 2

A: ESCC patients at stages III- IV(A) showing higher mRNA expression level of beta-catenin than ESCC patients at stages I-II(B). Y: observed lymph node metastasis, N: no lymph node metastasis. ESCC patients with lymph node metastasis had higher mRNA expression level of beta-catenin than ESCC patients with no lymph node metastasis.